28299657|t|RUNX1-ETO Leukemia
28299657|a|AML1-ETO leukemia is the most common cytogenetic subtype of acute myeloid leukemia, defined by the presence of t(8;21). Remarkable progress has been achieved in understanding the molecular pathogenesis of AML1-ETO leukemia. Proteomic surveies have shown that AML-ETO forms a stable complex with several transcription factors, including E proteins. Genome-wide transcriptome and ChIP-seq analyses have revealed the genes directly regulated by AML1-ETO, such as CEBPA. Several lines of evidence suggest that AML1-ETO suppresses endogenous DNA repair in cells to promote mutagenesis, which facilitates acquisition of cooperating secondary events. Furthermore, it has become increasingly apparent that a delicate balance of AML1-ETO and native AML1 is important to sustain the malignant cell phenotype. Translation of these findings into the clinical setting is just beginning.
28299657	0	9	RUNX1-ETO	T116	C0665119
28299657	10	18	Leukemia	T191	C0023418
28299657	19	27	AML1-ETO	T116	C0665119
28299657	28	36	leukemia	T191	C0023418
28299657	56	67	cytogenetic	T019	C0000768
28299657	68	75	subtype	T185	C0449560
28299657	79	101	acute myeloid leukemia	T191	C0023440
28299657	130	137	t(8;21)	T049	C3897139
28299657	198	207	molecular	T080	C1521991
28299657	208	220	pathogenesis	T046	C0699748
28299657	224	232	AML1-ETO	T116	C0665119
28299657	233	241	leukemia	T191	C0023418
28299657	243	252	Proteomic	T091	C0872252
28299657	253	261	surveies	T170	C0038951
28299657	278	285	AML-ETO	T116	C1332085
28299657	294	300	stable	T080	C0205360
28299657	301	308	complex	T104	C1704241
28299657	322	343	transcription factors	T116,T123	C0040648
28299657	355	365	E proteins	T116,T123	C0599561
28299657	367	392	Genome-wide transcriptome	T086	C3178810
28299657	397	405	ChIP-seq	T063	C3831111
28299657	406	414	analyses	T062	C0936012
28299657	433	438	genes	T028	C0017337
28299657	461	469	AML1-ETO	T116	C0665119
28299657	479	484	CEBPA	T116,T123	C0378310
28299657	503	511	evidence	T078	C3887511
28299657	525	533	AML1-ETO	T116	C0665119
28299657	534	544	suppresses	T169	C1260953
28299657	545	555	endogenous	T169	C0205227
28299657	556	566	DNA repair	T045	C0012899
28299657	570	575	cells	T025	C0007634
28299657	579	586	promote	T052	C0033414
28299657	587	598	mutagenesis	T044	C0079866
28299657	728	735	balance	T040	C0014653
28299657	739	747	AML1-ETO	T116	C0665119
28299657	759	763	AML1	T116,T123	C0215508
28299657	792	806	malignant cell	T025	C0334227
28299657	807	816	phenotype	T032	C0031437
28299657	818	829	Translation	T057	C0040710
28299657	839	847	findings	T033	C0243095
28299657	857	873	clinical setting	T082	C3176918